Ketamine's brain secrets: new study aims to unlock rapid depression relief

NCT ID NCT06698848

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study gives ketamine to 120 people with major depression and suicidal thoughts who are not on other psychiatric medications. Researchers use brain scans and a gentle nose swab to see how ketamine changes brain connections and neuron activity. The goal is to understand why ketamine works so quickly, which could lead to better treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ketamine

What this could lead to

If successful, this could reveal exactly how ketamine works in the brain, paving the way for new, safer depression treatments.

What could go wrong

This is an early phase 1 study focused on understanding mechanisms, not proving effectiveness. Results may not lead to new treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder major depressive disorder Suicide

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Massachusetts General Hosipital

    Boston, Massachusetts, 02114, United States